Astrana Health Valuation
| ASTH Stock | 22.74 0.33 1.47% |
At this time, the firm appears to be undervalued. Astrana Health shows a prevailing Real Value of USD28.5 per share. The current price of the firm is USD22.74. Our model approximates the value of Astrana Health from analyzing the firm fundamentals such as Return On Equity of 0.0183, profit margin of 0 %, and Current Valuation of 1.75 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Astrana Health's valuation include:
Price Book 1.4506 | Enterprise Value | Enterprise Value Ebitda 16.1691 | Price Sales 0.3938 | Forward PE 23.0415 |
Undervalued
Today
Please note that Astrana Health's price fluctuation is not too volatile at this time. Calculation of the real value of Astrana Health is based on 3 months time horizon. Increasing Astrana Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Astrana Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Astrana Stock. However, Astrana Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 22.74 | Real 28.5 | Target 36.89 | Hype 22.86 | Naive 18.2 |
The intrinsic value of Astrana Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Astrana Health's stock price.
Estimating the potential upside or downside of Astrana Health helps investors to forecast how Astrana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Astrana Health more accurately as focusing exclusively on Astrana Health's fundamentals will not take into account other important factors: When choosing an evaluation method for Astrana Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Astrana Health Cash |
|
Astrana Revenue by Product
Astrana Health Total Value Analysis
Astrana Health is presently anticipated to have valuation of 1.75 B with market capitalization of 1.14 B, debt of 471.84 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Astrana Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.75 B | 1.14 B | 471.84 M |
Astrana Health Investor Information
About 22.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. Astrana Health had not issued any dividends in recent years. The entity had 1:10 split on the 27th of April 2015. Astrana Health is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.Astrana Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Astrana Health has an asset utilization ratio of 150.16 percent. This signifies that the Company is making USD1.5 for each dollar of assets. An increasing asset utilization means that Astrana Health is more efficient with each dollar of assets it utilizes for everyday operations.Astrana Health Profitability Analysis
Considering the key profitability indicators obtained from Astrana Health's historical financial statements, Astrana Health is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in March. Profitability indicators assess Astrana Health's ability to earn profits and add value for shareholders.Net Income | First Reported 2001-09-30 | Previous Quarter 9.4 M | Current Value 373 K | Quarterly Volatility 8.1 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.2 | 0.15 |
|
|
For Astrana Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Astrana Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Astrana Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Astrana Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Astrana Health over time as well as its relative position and ranking within its peers.
Astrana Health Earnings per Share Projection vs Actual
The next projected EPS of Astrana Health is estimated to be 0.1987 with future projections ranging from a low of 0.08 to a high of 0.31. Astrana Health's most recent 12-month trailing earnings per share (EPS TTM) is at 0.19. Please be aware that the consensus of earnings estimates for Astrana Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Astrana Health Earnings Estimation Breakdown
The calculation of Astrana Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Astrana Health is estimated to be 0.1987 with the future projection ranging from a low of 0.08 to a high of 0.31. Please be aware that this consensus of annual earnings estimates for Astrana Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.08 Lowest | Expected EPS | 0.31 Highest |
Astrana Health Earnings Projection Consensus
Suppose the current estimates of Astrana Health's value are higher than the current market price of the Astrana Health stock. In this case, investors may conclude that Astrana Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Astrana Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 11 | 70.91% | 0.0 | 0.1987 | 0.19 |
Astrana Health Ownership Allocation
Astrana Health holds a total of 50.16 Million outstanding shares. Over half of Astrana Health's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Astrana Health Profitability Analysis
The company reported the previous year's revenue of 2.03 B. Net Income was 49.93 M with profit before overhead, payroll, taxes, and interest of 296.97 M.About Astrana Health Valuation
An absolute valuation paradigm, as applied to Astrana Stock, attempts to find the value of Astrana Health based on its fundamental and basic technical indicators. By analyzing Astrana Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Astrana Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Astrana Health. We calculate exposure to Astrana Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Astrana Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 312.1 M | 327.7 M | |
| Pretax Profit Margin | 0.04 | 0.04 | |
| Operating Profit Margin | 0.04 | 0.05 | |
| Net Profit Margin | 0.02 | 0.02 | |
| Gross Profit Margin | 0.15 | 0.20 |
Astrana Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 48.2 M | |
| Quarterly Earnings Growth Y O Y | -0.977 | |
| Forward Price Earnings | 23.0415 |
Astrana Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Astrana Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Astrana we look at many different elements of the entity such as Astrana's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Astrana Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Astrana Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Astrana Health's worth.Complementary Tools for Astrana Stock analysis
When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |